Whole-brain mapping of venous vessel size in humans using the hypercapnia-induced BOLD effect

NeuroImage

Volumn 51, Issue 2, 2010, Pages 765-774

  Jochimsen, Thies H ^a,b   Ivanov, Dimo ^b   Ott, Derek V M ^b   Heinke, Wolfgang ^c   Turner, Robert ^b   Möller, Harald E ^b   Reichenbach, Jürgen R ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Blood volume; BOLD; Hypercapnia; Vessel density; Vessel size imaging

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADULT; ARTICLE; BLOOD OXYGENATION; BLOOD VOLUME; BRAIN BLOOD VESSEL; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERCAPNIA; IMAGE RECONSTRUCTION; MALE; MICROVASCULATURE; MONTE CARLO METHOD; MORPHOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; STROKE; TIME; TUMOR VASCULARIZATION; VEIN DIAMETER; VENOUS BLOOD;

ADULT; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; HYPERCAPNIA; MAGNETIC RESONANCE IMAGING; MALE; VEINS; YOUNG ADULT;

EID: 77951975595     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.02.037     Document Type: Article

References (51)

1. Bandettini P.A., Wong E.C. A hypercapnia-based normalization method for improved spatial localization of human brain activation with fMRI. NMR Biomed. 1997, 10:197-203.
2. Bosomtwi A., Jiang Q., Ding G.L., Zhang L., Zhang Z.G., Lu M., Ewing J.R., Chopp M. Quantitative evaluation of microvascular density after stroke in rats using MRI. J. Cereb. Blood Flow Metab. 2008, 28:1978-1987.
3. Boxerman J.L., Hamberg L.M., Rosen B.P., Weisskoff R.M. MR contrast due to intravascular magnetic susceptibility perturbations. Magn. Reson. Med. 1995, 34:555-566.
4. Bright M.G., Bulte D.P., Jezzard P., Duyn J.H. Characterization of regional heterogeneity in cerebrovascular reactivity dynamics using novel hypocapnia task and BOLD fMRI. NeuroImage 2009, 48:166-175.
5. Bulte D., Chiarelli P., Wise R., Jezzard P. Measurement of cerebral blood volume in humans using hyperoxic MRI contrast. J. Magn. Reson. Imaging 2007, 26:894-899.
6. Cameron O.G., Modell J.G., Hariharan M. Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci. 1990, 47:1141-1146.
7. Cohen E.R., Rostrup E., Sidaros K., Lund T.E., Paulson O.B., Uǧurbil K., Kim S.-G. Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences. NeuroImage 2004, 23:613-624.
8. Dennie J., Mandeville J.B., Boxerman J.L., Packard S.D., Rosen B.R., Weisskoff R.M. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn. Reson. Med. 1998, 40:793-799.
9. Donahue K.M., Krouwer H.G., Rand S.D., Pathak A.P., Marszalkowski C.S., Censky S.C., Prost R.W. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn. Reson. Med. 2000, 43:845-853.
10. Fisel C.R., Ackerman J.L., Buxton R.B., Garrido L., Belliveau J.W., Rosen B.R., Brady T.J. MR contrast due to microscopically heterogenous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn. Reson. Med. 1991, 17:336-347.
11. Glover G.H., Li T.-Q., Ress D. Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magn. Reson. Med. 2000, 44:162-167.
12. He X., Yablonskiy D.A. Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magn. Reson. Med. 2007, 57:115-126.
13. Hoogenraad F.G.C., Reichenbach J.R., Haacke E.M., Lai S., Kuppusamy K., Sprenger M. In vivo measurement of changes in venous blood-oxygenation with high resolution functional MRI at 0.95Tesla by measuring changes in susceptibility and velocity. Magn. Reson. Med. 1998, 39:97-107.
14. Huo D., Wilson D.L. Robust GRAPPA reconstruction and its evaluation with the perceptual difference model. J. Magn. Reson. Imaging 2008, 27:1412-1420.
15. Jensen J.H., Chandra R. MR imaging of microvasculature. Magn. Reson. Med. 2000, 44:224-230.
16. Jensen J.H., Lu H., Inglese M. Microvessel density estimation in the human brain by means of dynamic contrast-enhanced echo-planar imaging. Magn. Reson. Med. 2006, 56:1145-1150.
17. Jochimsen T.H., Möller H.E. Increasing specificity in functional magnetic resonance imaging by estimation of vessel size based on changes in blood oxygenation. NeuroImage 2008, 40:228-236.
18. Jochimsen T.H., von Mengershausen M. ODIN-object-oriented development interface for NMR. J. Magn. Reson. 2004, 170:67-78.
19. Jochimsen T.H., Newbould R.D., Skare S.T., Clayton D.B., Albers G.W., Moseley M.E., Bammer R. Identifying systematic errors in quantitative dynamic-susceptibility contrast perfusion imaging by high resolution multi-echo parallel EPI. NMR Biomed. 2007, 20:429-438.
20. Kastrup A., Li T.-Q., Takahashi A., Glover G.H., Moseley M.E. Functional magnetic resonance imaging of regional cerebral blood oxygenation changes during breath holding. Stroke 1998, 29:2641-2645.
21. Kiselev V.G. Transverse relaxation effect of MRI contrast agents: a crucial issue for quantitative measurement of cerebral perfusion. J. Magn. Reson. Imaging 2005, 22:693-696.
22. Kiselev V.G., Strecker R., Ziyeh S., Speck O., Hennig J. Vessel size imaging in humans. Magn. Reson. Med. 2005, 53:553-563.
23. Kontos H.A., Raper A.J., Patterson J.L. Analysis of vasoactivity of local pH, PCO2 and bicarbonate on pial vessels. Stroke 1977, 8:358-360.
24. Li A., Wong C.S., Wong M.K., Lee C.M., Au Yeung M.C. Acute adverse reactions to magnetic resonance contrast media-gadolinium chelates. Br. J. Radiol. 2006, 79:368-371.
25. Lin C.-Y., Chang C., Cheung W.-M., Lin M.-H., Chen J.-J., Hsu C.Y., Chen J.-H., Lin T.-N. Dynamic changes in vascular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats: evaluation with contrast-enhanced magnetic resonance imaging. J. Cereb. Blood Flow Metab. 2008, 28:1491-1501.
26. Maas L.C., deB.Frederick B., Renshaw P.F. Decoupled automated rotational and translational registration for functional MRI time series data: the DART registration algorithm. Magn. Reson. Med. 1997, 37:131-139.
27. Mathew R.J., Wilson W.H. Caffeine induced changes in cerebral circulation. Stroke 1985, 16:814-817.
28. Poser B.A., Versluis M.J., Hoogduin J.M., Norris D.G. BOLD contrast sensitivity enhancement and artifact reduction with multiecho EPI: parallel-acquired inhomogeneity-densitized fMRI. Magn. Reson. Med. 2006, 55:1227-1235.
29. Δ in cat brain during hypoxia and hypercapnia. NeuroImage 1997, 6:191-200.
30. Quarles C., Schmainda K. Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI. Magn. Reson. Med. 2007, 57:680-687.
31. Reichenbach J.R., Venkatesan R., Schillinger D.J., Kido D.K., Haacke E.M. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997, 204:272-277.
32. Rempp K.A., Brix G., Wenz F., Becker C.R., Gückel F., Lorenz W.J. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994, 193:637-641.
33. Robinson S.P., Howe F.A., Griffiths J.R. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33:855-859.
34. Robinson S.P., Rijken P.F.J.W., Howe F.A., McSheehy P.M.J., van der Sanden B.P.J., Heerschap A., Stubbs M., van der Kogel A.J., Griffiths J.R. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J. Magn. Reson. Imaging 2003, 17:445-454.
35. Schwarzbauer C., Heinke W. Investigating the dependence of BOLD contrast on oxidative metabolism. Magn. Reson. Med. 1999, 41:537-543.
36. Sedlacik J., Helm K., Rauscher A., Stadler J., Mentzel H.-J., Reichenbach J. Investigations on the effect of caffeine on cerebral venous vessel contrast by using susceptibility-weighted imaging (swi) at 1.5, 3 and 7T. NeuroImage 2008, 40:11-18.
37. Sedlacik J., Kutschbach C., Rauscher A., Deistung A., Reichenbach J.R. Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI). NeuroImage 2008, 43:36-43.
38. Silvennoinen M.J., Clingman C.S., Golay X., Kauppinen R.A., van Zijl P.C.M. Comparison of the dependence of blood R2 and R2 on oxygen saturation at 1.5 and 4.7Tesla. Magn. Reson. Med. 2003, 49:47-60.
39. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
40. *, and non-Lorentzian signal behavior. Magn. Reson. Med. 2001, 45:533-542.
41. Thomsen H.S. Is NSF only the tip of the gadolinium toxicity iceberg?. J. Magn. Reson. Imaging 2008, 28:284-286.
42. Troprès I., Grimault S., Vaeth A., Grillon E., Julien C., Payen J.-F., Lamalle L., Décorps M. Vessel size imaging. Magn. Reson. Med. 2001, 45:397-408.
43. Troprès I., Lamalle L., Péoc'h M., Farion R., Usson Y., Décorps M., Rémy C. In vivo assessment of tumoral angiogenesis. Magn. Reson. Med. 2004, 51:533-541.
44. Uludag K., Müller-Bierl B., Uǧurbil K. An integrative model for neuronal activity-induced signal changes for gradient and spin echo functional imaging. NeuroImage 2009, 48:150-165.
45. Ungersma S.E., Ho C., Pacheco G., Ross J., Greve J.M., Peale F.V., Ross S., Carano R.A. Vessel size index MRI: validation with micro-CT angiography. Proc ISMRM 2008, 16:449.
46. Valable S., Lemasson B., Farion R., Beaumont M., Segebarth C., Remy C., Barbier E.L. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed. 2008, 21:1043-1056.
47. Yablonskiy D.A., Haacke E.M. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994, 32:749-763.
48. Yacoub E., Duong T.Q., van de Moortele P.-F., Lindquist M., Adriany G., Kim S.-G., Uǧurbil K., Hu X. Spin-echo fMRI in humans using high spatial resolutions and high magnetic fields. Magn. Reson. Med. 2003, 49:655-664.
49. Zhang Y., Brady M., Smith S.M. Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans. Med. Imaging 2001, 20:45-57.
50. Zhao F., Jin T., Wang P., Hu X., Kim S.-G. Sources of phase changes in BOLD and CBV-weighted fMRI. Magn. Reson. Med. 2007, 57:520-527.
51. Zhao J.M., Clingman C.S., Närväinen M.J., Kauppinen R.A., Zijl P.C.M. Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn. Reson. Med. 2007, 58:592-596.